GANX (STOCKS)
Gain Therapeutics, Inc. Common Stock
$1.740000
-0.040000 (-2.25%)
Prev close: $1.780000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gene C. Mack
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $68.66M
- Employees
- 25
- P/E (TTM)
- -2.72
- P/B (TTM)
- 10.59
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.15 | $-0.15 | +0.0030 | +1.96% |
|
Jun 2025 (Q2)
|
$-0.19 | $-0.17 | -0.0183 | -10.66% |
|
Mar 2025 (Q1)
|
$-0.16 | $-0.18 | +0.0236 | +12.85% |
|
Dec 2024 (Q4)
|
$-0.11 | $-0.19 | +0.0770 | +41.18% |
Financial Statements
| Revenues | -$305.24K |
| Operating Expenses | $17.58M |
| Research and Development | $9.09M |
| Other Operating Expenses | $8.49M |
| Operating Income/Loss | -$17.58M |
| Income/Loss From Continuing Operations After Tax | -$19.39M |
| Income/Loss From Continuing Operations Before Tax | -$18.10M |
| Income Tax Expense/Benefit | $1.30M |
| Net Income/Loss | -$19.39M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.61 |
| Diluted Earnings Per Share | -$0.61 |
| Basic Average Shares | 32,959,425 |
| Diluted Average Shares | 32,959,425 |
| Assets | $10.97M |
| Current Assets | $10.52M |
| Noncurrent Assets | $454.41K |
| Fixed Assets | $85.57K |
| Other Non-current Assets | $368.84K |
| Liabilities | $5.06M |
| Current Liabilities | $4.17M |
| Accounts Payable | $1.58M |
| Other Current Liabilities | $2.59M |
| Noncurrent Liabilities | $891.65K |
| Long-term Debt | $424.34K |
| Other Non-current Liabilities | $467.31K |
| Equity | $5.91M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.91M |
| Liabilities And Equity | $10.97M |
| Net Cash Flow From Operating Activities | -$17.30M |
| Net Cash Flow From Operating Activities, Continuing | -$17.30M |
| Net Cash Flow From Investing Activities | $1.53M |
| Net Cash Flow From Investing Activities, Continuing | $1.91M |
| Net Cash Flow From Financing Activities | $14.21M |
| Net Cash Flow From Financing Activities, Continuing | $14.21M |
| Exchange Gains/Losses | -$104.32K |
| Net Cash Flow | -$2.04M |
| Net Cash Flow, Continuing | -$1.94M |
| Comprehensive Income/Loss | -$19.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.07M |
| Other Comprehensive Income/Loss | -$10.77M |
| Other Comprehensive Income/Loss Attributable To Parent | $320.41K |